Inhibition of Interleukin-1β-Induced Group IIA Secretory Phospholipase A2 Expression by Peroxisome Proliferator-Activated Receptors (PPARs) in Rat Vascular Smooth Muscle Cells: Cooperation between PPARβ and the Proto-Oncogene BCL-6

REFERENCES

• Ahmad, K. F., A. Melnick, S. Lax, D. Bouchard, J. Liu, C. L. Kiang, S. Mayer, S. Takahashi, J. D. Licht, and G. G. Prive. 2003. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell 12:1551–1564.
   PubMed Web of Science ®Google Scholar
• Antonio, V., A. Brouillet, B. Janvier, C. Monne, G. Bereziat, M. Andreani, and M. Raymondjean. 2002. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors. Biochem. J. 368:415–424.
   PubMedGoogle Scholar
• Antonio, V., B. Janvier, A. Brouillet, M. Andreani, and M. Raymondjean. 2003. Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. Biochem. J. 376:351–360.
   PubMedGoogle Scholar
• Barak, Y., D. Liao, W. He, E. S. Ong, M. C. Nelson, J. M. Olefsky, R. Boland, and R. M. Evans. 2002. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA 99:303–308.
   PubMed Web of Science ®Google Scholar
• Barish, G. D., V. A. Narkar, and R. M. Evans. 2006. PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Investig. 116:590–597.
   PubMed Web of Science ®Google Scholar
• Berry, E. B., J. A. Keelan, R. J. Helliwell, R. S. Gilmour, and M. D. Mitchell. 2005. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. Mol. Pharmacol. 68:169–178.
   PubMedGoogle Scholar
• Brown, J. D., and J. Plutzky. 2007. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 115:518–533.
   PubMed Web of Science ®Google Scholar
• Castrillo, A., and P. Tontonoz. 2004. PPARs in atherosclerosis: the clot thickens. J. Clin. Investig. 114:1538–1540.
   PubMedGoogle Scholar
• Cheng, L., G. Ding, Q. Qin, Y. Huang, W. Lewis, N. He, R. M. Evans, M. D. Schneider, F. A. Brako, Y. Xiao, Y. E. Chen, and Q. Yang. 2004. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10:1245–1250.
   PubMed Web of Science ®Google Scholar
• Cipollone, F., C. Prontera, B. Pini, M. Marini, M. Fazia, D. De Cesare, A. Iezzi, S. Ucchino, G. Boccoli, V. Saba, F. Chiarelli, F. Cuccurullo, and A. Mezzetti. 2001. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104:921–927.
   PubMed Web of Science ®Google Scholar
• Clément, N., M. Glorian, M. Raymondjean, M. Andreani, and I. Limon. 2006. PGE2 amplifies the effects of IL-1beta on vascular smooth muscle cell de-differentiation: a consequence of the versatility of PGE2 receptors 3 due to the emerging expression of adenylyl cyclase 8. J. Cell. Physiol. 208:495–505.
   PubMedGoogle Scholar
• Dent, A. L., F. H. Vasanwala, and L. M. Toney. 2002. Regulation of gene expression by the proto-oncogene BCL-6. Crit. Rev. Oncol. Hematol. 41:1–9.
   PubMedGoogle Scholar
• Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli. 1996. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384:39–43.
   PubMed Web of Science ®Google Scholar
• Diep, Q. N., R. M. Touyz, and E. L. Schiffrin. 2000. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 36:851–855.
   PubMed Web of Science ®Google Scholar
• Elbashir, S. M., J. Martinez, A. Patkaniowska, W. Lendeckel, and T. Tuschl. 2001. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20:6877–6888.
   PubMed Web of Science ®Google Scholar
• François, M., P. Richette, L. Tsagris, M. Raymondjean, M. C. Fulchignoni-Lataud, C. Forest, J. F. Savouret, and M. T. Corvol. 2004. Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element. J. Biol. Chem. 279:28411–28418.
   PubMedGoogle Scholar
• Hajjar, D. P., and K. B. Pomerantz. 1992. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J. 6:2933–2941.
   PubMedGoogle Scholar
• Hurt-Camejo, E., S. Andersen, R. Standal, B. Rosengren, P. Sartipy, E. Stadberg, and B. Johansen. 1997. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17:300–309.
   PubMed Web of Science ®Google Scholar
• Ivandic, B., L. W. Castellani, X. P. Wang, J. H. Qiao, M. Mehrabian, M. Navab, A. M. Fogelman, D. S. Grass, M. E. Swanson, M. C. de Beer, F. de Beer, and A. J. Lusis. 1999. Role of group II secretory phospholipase A2 in atherosclerosis. 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler. Thromb. Vasc. Biol. 19:1284–1290.
   PubMed Web of Science ®Google Scholar
• Jacques, C., G. Bereziat, L. Humbert, J. L. Olivier, M. T. Corvol, J. Masliah, and F. Berenbaum. 1997. Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes. J. Clin. Investig. 99:1864–1872.
   PubMedGoogle Scholar
• Jaross, W., R. Eckey, and M. Menschikowski. 2002. Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis. Eur. J. Clin. Investig. 32:383–393.
   PubMedGoogle Scholar
• Jaulmes, A., B. Janvier, M. Andreani, and M. Raymondjean. 2005. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25:1161–1167.
   PubMedGoogle Scholar
• Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82–86.
   PubMed Web of Science ®Google Scholar
• Kharroubi, I., C. H. Lee, P. Hekerman, M. I. Darville, R. M. Evans, D. L. Eizirik, and M. Cnop. 2006. BCL-6: a possible missing link for anti-inflammatory PPAR-delta signalling in pancreatic beta cells. Diabetologia 49:2350–2358.
   PubMed Web of Science ®Google Scholar
• Lee, C. H., A. Chawla, N. Urbiztondo, D. Liao, W. A. Boisvert, R. M. Evans, and L. K. Curtiss. 2003. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302:453–457.
   PubMed Web of Science ®Google Scholar
• Lusis, A. J. 2000. Atherosclerosis. Nature 407:233–241.
   PubMed Web of Science ®Google Scholar
• Marx, N., H. Duez, J. C. Fruchart, and B. Staels. 2004. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 94:1168–1178.
   PubMed Web of Science ®Google Scholar
• Murakami, M., H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh, and I. Kudo. 2000. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275:32783–32792.
   PubMed Web of Science ®Google Scholar
• Oliver, W. R., Jr., J. L. Shenk, M. R. Snaith, C. S. Russell, K. D. Plunket, N. L. Bodkin, M. C. Lewis, D. A. Winegar, M. L. Sznaidman, M. H. Lambert, H. E. Xu, D. D. Sternbach, S. A. Kliewer, B. C. Hansen, and T. M. Willson. 2001. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA 98:5306–5311.
   PubMed Web of Science ®Google Scholar
• Planavila, A., R. Rodriguez-Calvo, M. Jove, L. Michalik, W. Wahli, J. C. Laguna, and M. Vazquez-Carrera. 2005. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc. Res. 65:832–841.
   PubMed Web of Science ®Google Scholar
• Ricote, M., J. Huang, L. Fajas, A. Li, J. Welch, J. Najib, J. L. Witztum, J. Auwerx, W. Palinski, and C. K. Glass. 1998. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 95:7614–7619.
   PubMed Web of Science ®Google Scholar
• Scholz-Pedretti, K., A. Gans, K. F. Beck, J. Pfeilschifter, and M. Kaszkin. 2002. Potentiation of TNF-alpha-stimulated group IIA phospholipase A(2) expression by peroxisome proliferator-activated receptor alpha activators in rat mesangial cells. J. Am. Soc. Nephrol. 13:611–620.
   PubMedGoogle Scholar
• Seimandi, M., G. Lemaire, A. Pillon, A. Perrin, I. Carlavan, J. J. Voegel, F. Vignon, J. C. Nicolas, and P. Balaguer. 2005. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. Anal. Biochem. 344:8–15.
   PubMed Web of Science ®Google Scholar
• Staels, B., W. Koenig, A. Habib, R. Merval, M. Lebret, I. P. Torra, P. Delerive, A. Fadel, G. Chinetti, J. C. Fruchart, J. Najib, J. Maclouf, and A. Tedgui. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393:790–793.
   PubMed Web of Science ®Google Scholar
• Takeda, N., M. Arima, N. Tsuruoka, S. Okada, M. Hatano, A. Sakamoto, Y. Kohno, and T. Tokuhisa. 2003. Bcl6 is a transcriptional repressor for the IL-18 gene. J. Immunol. 171:426–431.
   PubMedGoogle Scholar
• Tanaka, T., J. Yamamoto, S. Iwasaki, H. Asaba, H. Hamura, Y. Ikeda, M. Watanabe, K. Magoori, R. X. Ioka, K. Tachibana, Y. Watanabe, Y. Uchiyama, K. Sumi, H. Iguchi, S. Ito, T. Doi, T. Hamakubo, M. Naito, J. Auwerx, M. Yanagisawa, T. Kodama, and J. Sakai. 2003. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA 100:15924–15929.
   PubMed Web of Science ®Google Scholar
• Tischfield, J. A. 1997. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem. 272:17247–17250.
   PubMed Web of Science ®Google Scholar
• Touqui, L., and M. Alaoui-El-Azher. 2001. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1:739–754.
   PubMedGoogle Scholar
• Tous, M., N. Ferre, A. Rull, J. Marsillach, B. Coll, C. Alonso-Villaverde, J. Camps, and J. Joven. 2006. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem. Biophys. Res. Commun. 340:1078–1084.
   PubMedGoogle Scholar
• Tunyaplin, C., A. L. Shaffer, C. D. Angelin-Duclos, X. Yu, L. M. Staudt, and K. L. Calame. 2004. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J. Immunol. 173:1158–1165.
   PubMed Web of Science ®Google Scholar
• Vosper, H., L. Patel, T. L. Graham, G. A. Khoudoli, A. Hill, C. H. Macphee, I. Pinto, S. A. Smith, K. E. Suckling, C. R. Wolf, and C. N. Palmer. 2001. The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J. Biol. Chem. 276:44258–44265.
   PubMed Web of Science ®Google Scholar
• Wang, Y. X., C. H. Lee, S. Tiep, R. T. Yu, J. Ham, H. Kang, and R. M. Evans. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113:159–170.
   PubMed Web of Science ®Google Scholar
• Yoshida, T., T. Fukuda, M. Hatano, H. Koseki, S. Okabe, K. Ishibashi, S. Kojima, M. Arima, I. Komuro, G. Ishii, T. Miki, S. Hirosawa, N. Miyasaka, M. Taniguchi, T. Ochiai, K. Isono, and T. Tokuhisa. 1999. The role of Bcl6 in mature cardiac myocytes. Cardiovasc. Res. 42:670–679.
   PubMedGoogle Scholar
• Zhang, J., M. Fu, X. Zhu, Y. Xiao, Y. Mou, H. Zheng, M. A. Akinbami, Q. Wang, and Y. E. Chen. 2002. Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells. J. Biol. Chem. 277:11505–11512.
   PubMed Web of Science ®Google Scholar